about
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South AfricaTB incidence in an adolescent cohort in South AfricaLessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis.Vaccine trials in the developing world: operational lessons learnt from a phase IV poliomyelitis vaccine trial in South Africa.Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial setting.Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.Screening for TB in high school adolescents in a high burden setting in South Africa.Analysis of time to regulatory and ethical approval of SATVI TB vaccine trials in South Africa.Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial.Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials.Risky behaviour and psychosocial correlates in adolescents - is there a link with tuberculosis?Safety and tolerability of sputum induction in adolescents and adults with suspected pulmonary tuberculosisKnowledge and acceptability of patient-specific infection control measures for pulmonary tuberculosisRandomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in AfricaDose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial
P50
Q33793322-718BB810-FD58-400A-8D07-0B7E93691B3BQ34637907-8D69120C-C391-4CC2-BC9D-844705F033C1Q36715923-C3231409-1C90-40D3-9131-8FA085DEB4B9Q37186951-F13A23C7-334B-424F-9EBC-58BB7DBAFE2BQ37957733-F9899B7B-7880-4261-B965-884371FEA6EDQ39579224-B3CB4AE3-92B9-42A6-96BE-B52088BB84CEQ40305488-94AC80D9-BC2F-48B2-8EEA-DE5C8C1D11D7Q41962727-8A99CD0C-D95F-4D27-A01A-7B6317BAF748Q42271717-CE683765-CEC6-4103-8618-F07B1374D60BQ42276672-CE23E43B-B1F0-408E-8D54-B8FBAB91FB38Q44052532-9E1681BA-18D8-4EF1-880E-03BB45245EEEQ44556197-F5502961-5D58-4621-89CF-06BD1E7130E0Q46914863-D6534F96-4B94-467B-A145-58377BCBC365Q48783795-0DB2B52D-AA50-4122-9DA7-F89BC31D8CCAQ57276339-5E8B9603-692D-4DE6-81CC-0B060B009087Q57663459-C835DF14-ACCC-45F8-9C6A-757BB9B4873FQ57663467-BB4610BC-0E99-46C0-A8A5-112A471E6A1EQ58827710-DC168F2E-7083-4ABE-B897-55246A17D332
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
H Geldenhuys
@ast
H Geldenhuys
@es
Hennie Geldenhuys
@en
Hennie Geldenhuys
@nl
type
label
H Geldenhuys
@ast
H Geldenhuys
@es
Hennie Geldenhuys
@en
Hennie Geldenhuys
@nl
altLabel
H Geldenhuys
@en
prefLabel
H Geldenhuys
@ast
H Geldenhuys
@es
Hennie Geldenhuys
@en
Hennie Geldenhuys
@nl
P106
P1153
35733666000
P21
P31
P496
0000-0002-2221-8997